Sticky sweetness gets more credit than it deserves. Honey sits in kitchens as a folk remedy while allergists keep repeating the same verdict: evidence that it treats seasonal allergies is thin to nonexistent. Clinical trials using local honey have not shown consistent reductions in sneezing, rhinorrhea, or itchy eyes when compared with placebo, even when participants consumed it daily for extended periods.

The problem is simple. Wrong target. Seasonal allergic rhinitis is driven by an IgE‑mediated immune response to airborne pollen grains, which reach nasal mucosa and trigger mast cell degranulation and histamine release. Most table honey contains only trace pollen, often from plants that are not the ones provoking symptoms outdoors, and pasteurization plus filtration can reduce that content even further, undercutting the supposed desensitization effect.

Stronger tools already exist. Allergen immunotherapy, delivered as subcutaneous injections or sublingual tablets, uses standardized pollen extracts at carefully escalated doses to induce immune tolerance through regulatory T‑cell pathways. Antihistamines and intranasal corticosteroids directly modulate histamine receptors and local inflammation. Against that pharmacologic and immunologic machinery, honey functions mainly as comfort food, not as a therapeutic strategy for hay fever.